Amcor appoints Peter Konieczny as CEO
Konieczny has served as Interim CEO since April 2024
Konieczny has served as Interim CEO since April 2024
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug
The Academy, led by Professor Ravi P Mahajan CBE, is set to harmonize the efforts of various Apollo entities
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
Dhiraj brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG
Birajeev is a seasoned Supply Chain leader with an experience of 23 years
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
The approval further adds to Biocon’s portfolio of complex drug products
Subscribe To Our Newsletter & Stay Updated